US Stock MarketDetailed Quotes
CDTTW CONDUIT PHARMACEUTICALS INC C/WTS 22/09/2028(TO PUR COM)
- 0.012
- +0.002+22.77%
Close Sep 13 16:00 ET
0Market Cap0.00P/E (TTM)
0.020High0.011Low9.03KVolume0.016Open0.010Pre Close173.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.16052wk High0.00P/B0Float Cap0.00752wk Low--Dividend TTM0Shs Float0.160Historical High--Div YieldTTM86.14%Amplitude0.007Historical Low0.019Avg Price1Lot Size
CONDUIT PHARMACEUTICALS INC C/WTS 22/09/2028(TO PUR COM) Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -252.68%-1.51M | -19.71%-2.36M | -240.91%-7.73M | -445.80%-4.8M | -524K | -429K | -149.87%-1.97M | -5.35%-2.27M | -880K | -788K |
| Net income from continuing operations | -155.60%-5.38M | -112.44%-3.55M | 89.05%-535K | 157.93%1.78M | --1.46M | ---2.11M | -444.63%-1.67M | -33.63%-4.89M | ---3.07M | ---307K |
| Operating gains losses | 183.65%2.12M | 459.56%489K | -493.63%-5.63M | -339.21%-2.98M | ---3.25M | --746K | -950.00%-136K | 859.06%1.43M | --1.25M | --16K |
| Other non cash items | 949.21%661K | 67.61%476K | 274.34%992K | 268.38%431K | --214K | --63K | --284K | --265K | --117K | ---- |
| Change In working capital | -21.79%610K | 70.83%-201K | -522.15%-2.52M | -950.60%-4.22M | --1.61M | --780K | -38.63%-689K | -56.08%596K | --496K | ---497K |
| -Change in prepaid assets | 61.94%-153K | 68.97%-153K | ---990K | ---1.08M | --988K | ---402K | ---493K | --0 | --0 | ---- |
| -Change in payables and accrued expense | -35.45%763K | 75.51%-48K | -354.74%-1.53M | -733.27%-3.14M | --624K | --1.18M | 60.56%-196K | -55.71%601K | --496K | ---497K |
| -Change in other current assets | ---- | ---- | 200.00%5K | --5K | ---- | ---- | ---- | ---5K | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -253.50%-1.51M | -19.64%-2.36M | -240.91%-7.73M | -445.80%-4.8M | ---524K | ---428K | -150.00%-1.97M | -5.35%-2.27M | ---880K | ---788K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -155.45%-224K | 0 | 496.17%725K | 1,020.37%497K | 67K | 404K | -243K | -183K | -54K | 0 |
| Net investment purchase and sale | ---- | ---- | 235.81%497K | ---- | ---- | ---- | ---- | --148K | ---- | ---- |
| Net other investing changes | ---- | ---- | 168.88%228K | --0 | --560K | ---89K | ---243K | ---331K | ---202K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -155.45%-224K | --0 | 496.17%725K | 1,020.37%497K | --67K | --404K | ---243K | ---183K | ---54K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 927.27%113K | 0 | 346.45%10.93M | -144.37%-414K | 9.11M | 11K | 181.37%2.22M | 28.98%2.45M | 933K | 789K |
| Net issuance payments of debt | --0 | --0 | 106.50%2.29M | -2,111.61%-8.49M | --8.54M | --11K | --2.22M | 60.90%1.11M | --422K | --0 |
| Net common stock issuance | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 10.83%1.34M | --511K | --789K |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | --498K | ---- | ---- | ---- | ---- | ---- |
| Net other financing activities | ---- | ---- | --8.64M | --8.49M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 927.27%113K | --0 | 346.45%10.93M | -144.37%-414K | --9.11M | --11K | 181.37%2.22M | 28.98%2.45M | --933K | --789K |
| Net cash flow | ||||||||||
| Beginning cash position | 22,950.00%1.84M | --4.23M | --0 | --8.64M | --0 | --8K | --0 | --0 | --0 | --0 |
| Current changes in cash | -12,392.31%-1.62M | -33,771.43%-2.36M | 393,000.00%3.93M | ---4.72M | --8.66M | ---13K | 600.00%7K | 99.60%-1K | ---- | --1K |
| Effect of exchange rate changes | -120.00%-1K | -2,800.00%-27K | 29,800.00%299K | 30,300.00%304K | ---11K | --5K | 0.00%1K | 0.00%1K | --1K | --1K |
| End cash Position | --219K | 22,950.00%1.84M | --4.23M | --4.23M | --8.64M | --0 | 300.00%8K | --0 | --0 | --2K |
| Free cash flow | -255.84%-1.52M | -19.64%-2.36M | -240.91%-7.73M | -445.80%-4.8M | ---524K | ---428K | -150.00%-1.97M | -5.35%-2.27M | ---880K | ---788K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data